Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe record history now lists revision v3.7.0, replacing the previous v3.6.6. This indicates an update to the study record's version history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.6.6 appears in the Record History, and the previous v3.6.5 entry is removed, indicating an updated version of the study record.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now shows a new revision entry: v3.6.5, replacing the previous v3.6.4. This indicates an incremental update to the page's version without altering study content.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the Study Record History, indicating an update to the page's version history. This reflects an internal update rather than changes to study content or user-facing elements.SummaryDifference0.1%

- Check101 days agoChange DetectedA new revision entry v3.6.3 was added to the Record History and the previous v3.6.2 entry was removed, updating the page's version history.SummaryDifference0.1%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.